Zhi Rong Qian

Zhi Rong Qian

UNVERIFIED PROFILE

Are you Zhi Rong Qian?   Register this Author

Register author
Zhi Rong Qian

Zhi Rong Qian

Publications by authors named "Zhi Rong Qian"

Are you Zhi Rong Qian?   Register this Author

100Publications

4384Reads

30Profile Views

Expression and clinical significance of immune checkpoint regulator B7-H3 (CD276) in human meningioma.

World Neurosurg 2019 Oct 16. Epub 2019 Oct 16.

Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China; Department of Critical Care Medicine, Huashan Hospital, Fudan University, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.10.044DOI Listing
October 2019

Baicalin Regulates Proliferation, Apoptosis, Migration, and Invasion in Mesothelioma.

Med Sci Monit 2019 Oct 31;25:8172-8180. Epub 2019 Oct 31.

Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang, China (mainland).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/MSM.919872DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844144PMC
October 2019

Calcium intake and colon cancer risk subtypes by tumor molecular characteristics.

Cancer Causes Control 2019 Jun 8;30(6):637-649. Epub 2019 Apr 8.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-019-01165-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546870PMC
June 2019

Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.

Clin Gastroenterol Hepatol 2018 10 24;16(10):1622-1631.e3. Epub 2018 Apr 24.

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.04.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151288PMC
October 2018

Statin use and pancreatic cancer risk in two prospective cohort studies.

J Gastroenterol 2018 Aug 23;53(8):959-966. Epub 2018 Jan 23.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-018-1430-xDOI Listing
August 2018

Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.

Clin Gastroenterol Hepatol 2018 08 21;16(8):1300-1306.e3. Epub 2018 Feb 21.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.02.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056316PMC
August 2018

Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index.

Pancreas 2017 Nov/Dec;46(10):1347-1353

From the *Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; †Medical Oncology Department 2, Chinese PLA General Hospital, Beijing, China; ‡Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA; §Collaborative Innovation Center of Tianjin for Medical Epigenetic, Key Laboratory of Hormone and Development (Ministry of Health), Metabolic Disease Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin; ∥College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China; ¶Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA; #Department of Epidemiology and Biostatistics, and the Ministry of Education Key Lab of Environment and Health, School of Public Health, Huazhong University of Science and Technology, Wuhan, China; **Department of Epidemiology, Harvard T.H. Chan School of Public Health; ††Department of Biostatistics, Harvard T.H. Chan School of Public Health; ‡‡Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School; §§Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; ∥∥Yale Cancer Center; ¶¶Department of Medicine, Yale University School of Medicine; and ##Smilow Cancer Hospital, New Haven, CT.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00006676-201711000-0001
Publisher Site
http://dx.doi.org/10.1097/MPA.0000000000000944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645256PMC
June 2018

Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.

Gastroenterology 2017 12 1;153(6):1517-1530.e14. Epub 2017 Sep 1.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.08.045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705461PMC
December 2017

Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.

JAMA Oncol 2017 Jul;3(7):921-927

Division of MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts4Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts7Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts9Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts13Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.6374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502000PMC
July 2017

Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?

J Diabetes Complications 2017 Jul 13;31(7):1228-1236. Epub 2017 Apr 13.

Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Ave., Boston, MA 02215. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2017.04.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501176PMC
July 2017

Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.

Gastroenterology 2017 06 27;152(8):1944-1953.e1. Epub 2017 Feb 27.

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.02.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447483PMC
June 2017

Cigarette Smoking and Pancreatic Cancer Survival.

J Clin Oncol 2017 Jun 30;35(16):1822-1828. Epub 2017 Mar 30.

Chen Yuan, Vicente Morales-Oyarvide, Ana Babic, Zhi Rong Qian, Douglas A. Rubinson, Kimmie Ng, Shuji Ogino, Charles S. Fuchs, and Brian M. Wolpin, Dana-Farber Cancer Institute and Harvard Medical School; Chen Yuan, Peter Kraft, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, Howard D. Sesso, and JoAnn E. Manson, Harvard School of Public Health; Ying Bao, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, John Michael Gaziano, Howard D. Sesso, JoAnn E. Manson, and Charles S. Fuchs, Brigham and Women's Hospital and Harvard Medical School; John Michael Gaziano, Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston; Clary B. Clish, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA; and Barbara B. Cochrane, University of Washington School of Nursing, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.2026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455596PMC
June 2017

Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.

J Clin Oncol 2017 Jun 13;35(16):1836-1844. Epub 2017 Apr 13.

Tsuyoshi Hamada, Zhi Rong Qian, Yohei Masugi, Juhong Yang, Kosuke Mima, Keisuke Kosumi, Li Liu, Yan Shi, Annacarolina da Silva, Mancang Gu, Wanwan Li, Jeffrey A. Meyerhardt, Marios Giannakis, Scott J. Rodig, Gordon J. Freeman, Charles S. Fuchs, Reiko Nishihara, and Shuji Ogino, Dana-Farber Cancer Institute and Harvard Medical School; Yin Cao, Mingyang Song, and Andrew T. Chan, Massachusetts General Hospital and Harvard Medical School; Yin Cao, Mingyang Song, Li Liu, NaNa Keum, Kana Wu, Edward L. Giovannucci, Daniel Nevo, Molin Wang, Reiko Nishihara, and Shuji Ogino, Harvard T.H. Chan School of Public Health; Jonathan A. Nowak, Xuehong Zhang, Edward L. Giovannucci, Marios Giannakis, Gordon J. Freeman, Molin Wang, Andrew T. Chan, Charles S. Fuchs, and Shuji Ogino, Brigham and Women's Hospital and Harvard Medical School, Boston; Marios Giannakis and Andrew T. Chan, Broad Institute of MIT and Harvard University, Cambridge, MA; Li Liu, Huazhong University of Science and Technology, Wuhan; Yan Shi, Chinese People's Liberation Army General Hospital, Beijing; and Mancang Gu, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455595PMC
June 2017

A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers.

Am J Gastroenterol 2017 03 24;112(3):493-501. Epub 2017 Jan 24.

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2016.589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342916PMC
March 2017

Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.

Oncoimmunology 2017 31;6(3):e1284720. Epub 2017 Jan 31.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1284720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384412PMC
January 2017

Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.

Gastroenterology 2016 11 27;151(5):879-892.e4. Epub 2016 Jul 27.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2016.07.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159194PMC
November 2016

Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.

Pancreas 2016 11;45(10):1386-1393

From the *Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; †Department of Geriatric Gastroenterology, Chinese PLA General Hospital, Beijing, China; ‡Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA; §Collaborative Innovation Center of Tianjin for Medical Epigenetics, Key Laboratory of Hormone and Development (Ministry of Health), Metabolic Disease Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China; ∥IPSEN Bioscience Inc, Global Drug Discovery Department, Cambridge, MA; ¶IPSEN Innovation, Global Drug Discovery Department, Les Ulis, France; Departments of #Biostatistics, and **Epidemiology, Harvard T.H. Chan School of Public Health, ††Massachusetts General Hospital, ‡‡Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, §§Department of Radiology, Massachusetts General Hospital, and ∥∥Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/pancreasjournal/2016/11000/Asso
Web Search
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067972PMC
http://dx.doi.org/10.1097/MPA.0000000000000700DOI Listing
November 2016

Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells.

JAMA Oncol 2016 Sep;2(9):1197-206

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston2Division of Gastroenterology, Massachusetts General Hospital, Boston12Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts13Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0605DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016204PMC
September 2016

MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.

Clin Cancer Res 2016 08 8;22(15):3841-8. Epub 2016 Mar 8.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970894PMC
August 2016

Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.

J Clin Oncol 2016 08 20;34(24):2899-905. Epub 2016 Jun 20.

Chen Yuan, Zhi Rong Qian, Ana Babic, Vicente Morales-Oyarvide, Douglas A. Rubinson, Kimmie Ng, Shuji Ogino, Charles S. Fuchs, and Brian M. Wolpin, Dana-Farber Cancer Institute and Harvard Medical School; Peter Kraft, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, Howard D. Sesso, Julie E. Buring, and JoAnn E. Manson, Harvard School of Public Health; Ying Bao, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, John Michael Gaziano, Howard D. Sesso, JoAnn E. Manson, and Charles S. Fuchs, Brigham and Women's Hospital and Harvard Medical School; John Michael Gaziano, Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA; Barbara B. Cochrane, University of Washington School of Nursing, Seattle, WA; Rowan T. Chlebowski, Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles Medical Center, Torrance, CA; and Linda G. Snetselaar, University of Iowa College of Public Health, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012662PMC
August 2016

Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Epidemiology 2016 07;27(4):602-11

From the aDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; bDivision of MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital, Boston, MA; cDepartment of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; dDepartment of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; eDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA; fDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA; gYale Institute for Network Science, Yale University, New Haven, CT; hInstitute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom; iDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA; jChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; kDepartment of Epidemiology, Richard M. Fairbanks School of Public Health, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN; lDivision of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; mDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA; nDivision of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA; and oDepartment of Emergency Medicine, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892980PMC
July 2016

Circulating Metabolites and Survival Among Patients With Pancreatic Cancer.

J Natl Cancer Inst 2016 Jun 11;108(6):djv409. Epub 2016 Jan 11.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (CY, ZRQ, DAR, KN, SO, MGVH, CSF, BMW); Broad Institute of MIT and Harvard University, Cambridge, MA (CBC, MGVH); Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China (CW); Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA (JRM, MET, MGVH); Department of Epidemiology (PK, SST, ELG, SO, MJS, JM, HDS, JEM), Department of Biostatistics (PK), and Department of Nutrition (ELG, MJS), Harvard School of Public Health, Boston, MA; Department of Pathology (SO), and Channing Division of Network Medicine (MKT, SST, YB, ELG, MJS, JM, JEM, CSF) and Division of Preventive Medicine (JMG, HDS, JEM), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (MZ, LTA); Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA (JMG); Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA (GLA); University of Washington School of Nursing, Seattle, WA (BBC); Division of Genomic Stability and DNA repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA (ACK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849356PMC
June 2016

Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Br J Nutr 2016 05;115(9):1643-60

1Department of Medical Oncology,Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue,Boston,MA 02215,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0007114516000696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890569PMC
May 2016

Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.

J Natl Cancer Inst 2016 Apr 23;108(4). Epub 2015 Nov 23.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (KI, RN, MY, PL, ZRQ, SAK, KM, YS, YI, CSF, SO); Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD (KI, CCH); Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan (KI); Department of Nutrition (MS, RN, EG, KW), Department of Epidemiology (MS, EG, SO), and Department of Biostatistics (RN), Harvard T. H. Chan School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine (SJ, XZ, EG, CSF, EC, ATC) and Department of Pathology (SO), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (PL, ATC); Department of Oncology, McGill University, Montreal, Quebec, Canada (MNP); Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (CSM); Section of Endocrinology, Boston VA Healthcare System, Harvard Medical School, Boston, MA (CSM); Department of Dermatology, Warren Alpert Medical School of Brown University, Province, RI (EC).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/108/4/djv363.full.pdf
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv36
Publisher Site
http://dx.doi.org/10.1093/jnci/djv363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668768PMC
April 2016

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.

Cell Rep 2016 Apr 14;15(4):857-865. Epub 2016 Apr 14.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.03.075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850357PMC
April 2016

MicroRNA MIR21 and T Cells in Colorectal Cancer.

Cancer Immunol Res 2016 Jan 29;4(1):33-40. Epub 2015 Sep 29.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703429PMC
January 2016

Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.

Br J Cancer 2016 Jan 7;114(2):199-206. Epub 2016 Jan 7.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue M420, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815802PMC
January 2016

Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival.

Am J Clin Nutr 2015 Nov 30;102(5):1134-41. Epub 2015 Sep 30.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.115.115162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625593PMC
November 2015

Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

JAMA Oncol 2015 Aug;1(5):653-61

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts3Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts5Department of Pathology, Brigham and Women's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.1377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537376PMC
August 2015

Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability.

J Natl Cancer Inst 2015 Apr 25;107(4). Epub 2015 Mar 25.

Department of Nutrition (MS, RN, KW, ELG) and Department of Epidemiology (MS, ELG, SO), Harvard School of Public Health, Boston, MA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (RN, ZRQ, SAK, YS, KM, AM, JY, CSF, SO); Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD (KI); Channing Division of Network Medicine, Department of Medicine (CSF, ELG, SO, ATC) and Department of Pathology (SO), Harvard Medical School, Brigham and Women's Hospital, Boston, MA; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA (ATC).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/107/4/djv007.full.pdf
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/djv007
Publisher Site
http://dx.doi.org/10.1093/jnci/djv007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402363PMC
April 2015

Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.

J Clin Oncol 2015 Jan 17;33(1):29-35. Epub 2014 Nov 17.

Chen Yuan, Douglas A. Rubinson, Zhi Rong Qian, Shuji Ogino, Kimmie Ng, Megan J. Gorman, Lauren K. Brais, Tingting Li, Matthew H. Kulke, Charles S. Fuchs, and Brian M. Wolpin, Dana-Farber Cancer Institute; Chen Wu, Peter Kraft, Shuji Ogino, Meir J. Stampfer, Frank B. Hu, and Edward L. Giovannucci, Harvard School of Public Health; and Ying Bao, Shuji Ogino, Kimmie Ng, Thomas E. Clancy, Richard S. Swanson, Meir J. Stampfer, Frank B. Hu, Edward L. Giovannucci, Matthew H. Kulke, Charles S. Fuchs, and Brian M. Wolpin, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.5688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268250PMC
January 2015

RNF43 is frequently mutated in colorectal and endometrial cancers.

Nat Genet 2014 Dec 26;46(12):1264-6. Epub 2014 Oct 26.

1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. [3] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283570PMC
December 2014

Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.

Am J Clin Nutr 2014 Dec 8;100(6):1479-88. Epub 2014 Oct 8.

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (RN, ZRQ, MY, KM, YS, SAK, KI, CSF, and SO); the Departments of Nutrition (RN, KW, and ELG), Epidemiology (MW, ELG, SO, and ESS), and Biostatistics (MW), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (MW, XZ, KW, ELG, ATC, CSF, and ESS); the Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan (YB); the Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); and Applied Cancer Research-Institution for Translational Research Vienna, Vienna, Austria (ESS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.114.095539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232016PMC
December 2014

Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.

World J Gastroenterol 2014 Dec;20(47):17699-708

Ting-Ting Li, Department of Geriatric Gastroenterology, Chinese PLA General Hospital, Beijing 100853, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i47.17699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273121PMC
December 2014

MicroRNAs in Human Pituitary Adenomas.

Int J Endocrinol 2014 8;2014:435171. Epub 2014 Dec 8.

Department of Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503, Japan ; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Room M420, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/435171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274667PMC
December 2014

Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.

J Natl Cancer Inst 2014 Sep 4;106(9). Epub 2014 Sep 4.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (KI, MY, RN, PL, ZRQ, AK, SAK, KM, YS, JAM, CSF, SO); Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD (KI, CCH); Department of Nutrition, Harvard School of Public Health, Boston, MA (RN, AK, KW); Gastrointestinal Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK (PL); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (SJ, XZ, EC, ATC, CSF); Department of Dermatology, The Warren Alpert Medical School of Brown University, Province, RI (EC); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); Department of Epidemiology, Harvard School of Public Health, Boston, MA (SO); Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA (SO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161997PMC
September 2014

Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.

Cancer Discov 2014 Apr 20;4(4):452-65. Epub 2014 Jan 20.

Departments of 1Medical Oncology and 2Cancer Biology, Dana-Farber Cancer Institute; 3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston; 4Broad Institute of Harvard and MIT, Cambridge; 5MGH Cancer Center, 6Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, Massachusetts; and 7Department of Surgery, Division of Biology and Biomedical Sciences, Washington University, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0646DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980023PMC
April 2014

Thrombospondin-1 is highly expressed in desmoplastic components of invasive ductal carcinoma of the breast and associated with lymph node metastasis.

J Med Invest 2013 ;60(1-2):91-6

Department of Human Pathology, Institute of Health Biosciences, the University of Tokushima Graduate School, Tokushima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2152/jmi.60.91DOI Listing
January 2014

Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.

World J Gastroenterol 2014 Jan;20(1):118-25

Ting-Ting Li, Jun Wan, Ben-Yan Wu, Department of Geriatric Gastroenterology, Chinese People's Liberation Army General Hospital, Beijing 100853, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i1.118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886000PMC
January 2014

Prediagnostic body mass index and pancreatic cancer survival.

J Clin Oncol 2013 Nov 21;31(33):4229-34. Epub 2013 Oct 21.

Chen Yuan, Shuji Ogino, Kimmie Ng, Zhi Rong Qian, Douglas A. Rubinson, and Brian M. Wolpin, Dana-Farber Cancer Institute; Ying Bao, Shuji Ogino, Kimmie Ng, Meir J. Stampfer, Edward L. Giovannucci, and Brian M. Wolpin, Brigham and Women's Hospital, Harvard Medical School; and Chen Wu, Peter Kraft, Shuji Ogino, Meir J. Stampfer, and Edward L. Giovannucci, Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.7532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821012PMC
November 2013

Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.

J Clin Oncol 2013 Sep 26;31(27):3418-25. Epub 2013 Aug 26.

Zhi Rong Qian, Monica Ter-Minassian, Jennifer A. Chan, Yu Imamura, Susanne M. Hooshmand, Aya Kuchiba, Teppei Morikawa, Lauren K. Brais, Anastassia Daskalova, Rachel Heafield, Charles S. Fuchs, Shuji Ogino, Matthew H. Kulke, Dana-Farber Cancer Institute and Harvard Medical School; Monica Ter-Minassian, Xihong Lin, David C. Christiani, Shuji Ogino, Harvard School of Public Health; David C. Christiani, Massachusetts General Hospital, Harvard Medical School; Charles S. Fuchs, Shuji Ogino, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/31/27/3418.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.46.6946
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.46.6946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770868PMC
September 2013

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

J Natl Cancer Inst 2013 Aug 22;105(15):1151-6. Epub 2013 Jul 22.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735463PMC
August 2013

A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.

Am J Epidemiol 2013 Jul 20;178(1):84-100. Epub 2013 Jun 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Epidemiology, Harvard School of Public Health, 450 Brookline Avenue, Room JF-215C, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/aje/kws431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698990PMC
July 2013

Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.

Cancer Epidemiol Biomarkers Prev 2013 Jun 29;22(6):1142-52. Epub 2013 Apr 29.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681847PMC
June 2013

Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.

Cancer Epidemiol Biomarkers Prev 2013 May 5;22(5):855-61. Epub 2013 Mar 5.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-12-1458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650127PMC
May 2013

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.

Eur J Cancer 2012 Dec 26;48(18):3405-13. Epub 2012 Jul 26.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.06.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613860PMC
December 2012

Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.

Int J Cancer 2012 Sep 19;131(5):1169-78. Epub 2011 Nov 19.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, and Department of Medicine Brigham and Women's Hospital, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.26495
Publisher Site
http://dx.doi.org/10.1002/ijc.26495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288809PMC
September 2012

Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.

Clin Cancer Res 2012 Sep 2;18(17):4753-63. Epub 2012 Jul 2.

Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Ave., Room JF-215C, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624899PMC
September 2012

Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.

Clin Cancer Res 2012 Apr 22;18(8):2257-68. Epub 2012 Feb 22.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2410DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628835PMC
April 2012

DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.

Hum Pathol 2010 Aug 8;41(8):1069-78. Epub 2010 Apr 8.

Department of Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2010.01.011DOI Listing
August 2010

Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas.

Endocr Pathol 2009 ;20(4):209-20

Department of Human Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto-cho, Tokushima 770-8503, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12022-009-9094-yDOI Listing
March 2010

Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity.

Endocr Pathol 2010 Mar;21(1):40-7

Department of Human Pathology, Institute of Health Bioscience, University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12022-009-9105-zDOI Listing
March 2010

Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas.

Histopathology 2010 Mar;56(4):501-9

Department of Human Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2010.03495.xDOI Listing
March 2010